Role of oxidative stress in pathogenesis of metabolic syndrome

Caspian Journal of Internal Medicine

Volumn 3, Issue 1, 2012, Pages 386-396

  Mahjoub, Soleiman ^a   Roudsari, Jila Masrour ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular diseases; Diabetes; Metabolic syndrome; Oxidative stress; Pathogenesis

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTANE; BIOLOGICAL MARKER; CARBONYLATED PROTEIN; HYDROGEN PEROXIDE; MALONALDEHYDE; NITRIC OXIDE; NITROSYLATED PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANGIOGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DNA DAMAGE; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; LUMINESCENCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PANCREAS ISLET BETA CELL DYSFUNCTION; PANCREAS ISLET DISEASE; PATHOGENESIS; REVIEW; RISK FACTOR;

EID: 84861932533     PISSN: 20086164     EISSN: 20086172     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Mahjoub S, Hasanjani Roshan MR, Gholami M. Evaluation of oxidative stress before and after treatment of patients with acute brucellosis. 12th Iranian Congress of Biochemistry and 4th International Congress of Biochemistry and Molecular Biology. 2011 Sep 6-9; Mashhad, Iran. Elsevier; Clinical Biochemistry 2011; 44: S365.
2. Mahjoub S, Jalali F, Seyyedi A. Status of Plasma Lipid Peroxidation in Patients with congestive Heart Failure. Euro Prevent Congress; 2009 may 6-9. Stockholm, Sweden. Eur J Cardiovasce Prev Rehabil 2009; 16: S 58.
3. Mahjoub S, Tamadoni A, Gorji R. Lipid and Protein Peroxidation in Patients with beta- Thalassemia Major and Intermedia. 3rd International Congress on Biochemistry and Molecular Biology (3rd ICBMB); 2009 Nov 16-19; Tehran Iran. J Iranian Chem Society, 2009; 6: 40.
4. Mahjoub S, Jalali F, Askari M. Plasma Total Antioxidant Capacity in Patients with Congestive Heart Failure. 16th Congress of Iranian Heart Association in collaboration with American College of Cardiology; 2008 Nov 18-21; Tehran Iran. Iranian Heart J 2008; Suppl 6: S55.
5. Mahjoub S, Tamadoni A, Nikoo M. Iron overload and oxidative stress in beta-Thalassemia patients in north of Iran. 11th Asian Pacific Congress of Clinical Biochemistry; 2007 Oct 14-16; Beijing, China. Chinese Med J 2007; 120: 187.
6. Mahjoub S, Tamadoni A, Nikoo M, Moghadamnia AA. Oral supplement of vitamin E and beta carotene reduce lipid & protein peroxidation of erythrocytes in beta-Thalassemia major patients. 9th Iranian Congress of Biochemistry and The Second International Congress of Biochemistry & Molecular Biology; 2007 Oct 29-Nov1; Shiraz, Iran. Arch Iran Med 2007; 10: S19.
7. Mahjoub S, Tamadoni M, Nikoo M, Moghadamnia AA. The effects of beta carotene and vitamin E on erythrocytes lipid peroxidation in beta-thalassemia. J Res Med Sci, 2007; 12: 301-7.
8. Sarkisian V, Dabidi Roshan V, Mahjoub S, Shahandeh S, Hosseinzadeh S. The effect of acute exercises on BDNF levels in rats' hippocampuse exposed by lead acetate. BECTHHK 2011; 16: 50-7.
9. Asali M, Dabidi Roshan V, Hosseinzadeh S, Mahjoub S, Hajizadeh Moghaddam A. The Role of Exercising and Curcumin on the Treatment of lead-induced Cardiotoxicity in Rats. Iran J Health Phys Act 2011; 2: 1-5.
10. Hosseinzadeh M, Dabidi-Roshan V, Hoseinzadeh S, Jolazadeh T, Mahjoub S. Lead Acetate, and Oxidant/Antioxidant, Inflammatory and Neurothrophic-Markers: Neuro and Cardio-protective Effects of Exercise training and Curcumin. 16th Annual Congress of the European College of Sport Science; 2011 July 6-9; Liverpool John Moores University, Liverpool, Uk.
11. Azizi G, Mohamadi F, Hajizadeh A, Dabidi roshan V, Mahjoub S. The effect of continuous training on homocysteine-induced lipid peroxidation in the dorsal hipocampus of the male rats. The First National Congress in Physiology of Exercise; 2009 March 14-16 Kermansha, Iran. 2009.
12. Gholami M , Hasanjani Roushan MR, Mahjoub S . How is total antioxidant status in plasma of Patients with Brucellosis? Caspian J Intern Med 2012. [In Press]
13. Mahjoub S, Haji Ahmadi M, Faramarzi M, Jalali F, Moazzezi Z, Sajjadi P. How is Lipid Profile and Morbidity Risk in Smokers and Nonsmokers? Casp J Intern Med 2010; 1: 128-33..
14. Moazzezi Z, Haji Ahmadi M, Mahjoub S, Ghorbani H, Faramarzi M Prevalence of the Metabolic Syndrome Defined Iranian National Committee of Obesity and ATP III Criteria among Adults in the Babol, Iran. Casp J Intern Med 2012. [In press]
15. Balkau B, Valensi P, Eschwège E, Slama G. A review of the metabolic syndrome. Diabetes Metab 2007; 33: 405-13.
16. Handelsman Y. Metabolic Syndrome Pathophysiology and Clinical Presentation Toxicol Pathol 2009; 37: 18-20.
17. Moller DE, Kaufman KD. Metabolic Syndrome: A Clinical and Molecular Perspective. Annu Rev Med 2005; 56: 45-62.
18. Rosen P, Nawroth PP, King G, et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001; 17:189-212.
19. Greene DA, Sima AA, Stevens MJ, Feldman EL, Lattimer SA 1992Complications: neuropathy, pathogenetic considerations. Diabetes Care 1992; 15: 1902-25.
20. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA 2003; 290:1884-90.
21. Fagot-Campagna A, Pettitt DJ, Engelgau MM. Type 2 diabetes among North American childrenand adolescents: an epidemiologic review and a public healthperspective. J Pediatr 2000; 136:664-72.
22. Windebank AJ, Feldman EL Diabetes and the nervous system. In: Aminoff MJ Neurology and general medicine. 3 rd ed. London:Churchill Livingstone; 2001; pp: 341-64.
23. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995; 64: 97-112.
24. Uemura S, Matsushita H, Li W, et al. 2001 Diabetes mellitus enhances vascularmatrix metalloproteinase activity: role of oxidative stress. Circ Res 2001; 88:1291-8.
25. Khodr B, Khalil Z. Modulation of inflammation by reactiveoxygen species: implications for aging and tissue repair. Free Radic Biol Med 2001; 30:1-8.
26. Lee MH, Hyun DH, Jenner P, Halliwell B. Effect of proteasomeinhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J Neurochem 2001; 78: 32-41.
27. Vazifeh D, Abdelghaffar H, Labro MT. Effect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcusaureus in comparison with roxithromycin. Antimicrob Agents Chemother 2001; 46: 1364-74.
28. Sawa A. Alteration of gene expression in Down's syndrome (DS) brains: its significance in neurodegeneration. J Neural Transm Suppl 2001; 61: 361-1.
29. Antunes F, Cadenas E. Estimation of H2O2 gradients across biomembranes. FEBS Lett 2000; 475: 121-6.
30. Pieper GM, Langenstroer P, Gross GJ. Hydroxyl radicalsmediate injury to endothelium-dependent relaxation in diabeticrat. Mol Cell Biochem 1993; 122: 139-45.
31. Feldman EL. Oxidative stress and diabetic neuropathy: a newunderstanding of an old problem. J Clin Invest 2003; 111:431-3.
32. Liu B, Gao HM, Wang JY, et al. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann NY Acad Sci 2002; 962: 318-1.
33. Ghafourifar P, Bringold U, Klein SD, Richter C. Mitochondrial nitric oxide synthase, oxidative stress and apoptosis. Biol Signals Recept 2001; 10:57-65.
34. Bardell AL, Macleod KM. Evidence for inducible nitric-oxidesynthase expression and activity in vascular smooth muscle ofstreptozotocin-diabetic rats. J Pharmacol Exp Ther 2001; 296:252-9.
35. Suzuki T, Tatsuoka H, Chiba T, et al. Beneficial effects of nitric oxidesynthase inhibition on the recovery of neurological function afterspinal cord injury in rats. Naunyn Schmiedebergs Arch Pharmacol 2001; 363:94-100.
36. Bruhwyler J, Chleide E, Liegeois JF, Carreer F. Nitric oxide:a new messenger in the brain. Neurosci Biobehav Rev 1993; 17: 373-84.
37. Huang PL, Lo EH. Genetic analysis of NOS isoforms usingnNOS and eNOS knockout animals. Prog Brain Res 1998; 118: 13-25.
38. Violi F, Marino R, Milite MT, Loffredo L Nitric oxide and itsrole in lipid peroxidation. Diabetes Metab Res Rev 1999; 15: 283-8.
39. Brown GC, Borutaite V. Nitric oxide, cytochrome c and mitochondria. Biochem Soc Symp 1999; 66: 17-25.
40. Andersson U, Leighton B, Young ME, Blomstrand E, Newsholme EA. Inactivation of aconitase and oxoglutarate dehydrogenase in skeletal muscle in vitro by superoxide anions and/or nitric oxide. Biochem Biophys Res Commun 1998; 249: 512-6.
41. Beckman KB, Ames BN. Endogenous oxidative damage of mtDNA. Mutat Res 1999; 424: 51-8.
42. Requena JR, Fu MX, Ahmed M et al. Lipoxidation products as biomarkers of oxidative damageto proteins during lipid peroxidation reactions. Nephrol DialTransplant 1996; 11: 48-53.
43. Metodiewa D, Koska C. Reactive oxygen species and reactivenitrogen species: relevance to cyto(neuro)toxic events and neurologicdisorders. An overview. Neurotox Res 2000; 1: 197-233.
44. De La Monte SM, Ganju N, Feroz N, et al. Oxygen free radical injury is sufficient tocause some Alzheimer-type molecular abnormalities in humanCNS neuronal cells. J Alzheimers Dis 2000; 2: 261-1.
45. Conn KJ, Ullman MD, Eisenhauer PB, Fine RE, Wells JM. Decreased expression of the NADH: ubiquinone oxidoreductase (complex I) subunit 4 in 1-methyl-4-phenylpyridinium-treated human neuroblastoma SH-SY5Y cells. Neurosci Lett 2001; 306: 145-8.
46. Paschen W, Mengesdorf T, Althausen S, Hotop S. Peroxidative stress selectively down-regulates the neuronal stress response activated under conditions of endoplasmic reticulum dysfunction. J Neurochem 2001; 76: 1916-24.
47. Pugazhenthi S, Nesterova A, Jambal P, et al. Oxidativestress-mediated down-regulation of bcl-2 promoter in hippocampal neurons. J Neurochem 2003; 84: 982-96.
48. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Radic Biol Med 2000; 28: 463-99.
49. Morel Y, Barouki R. Repression of gene expression by oxidativestress. Biochem J 1999; 342: 481-96.
50. Bohr VA, Dianov GL. Oxidative DNA damage processing in nuclear and mitochondrial DNA. Biochimie 1999; 81: 155-60.
51. Nagley P, Zhang C, Lim ML, Merhi M, Needham BE, Khalil Z. Mitochondrial DNA deletions parallel age-linked decline inrat sensory nerve function. Neurobiol Aging 2001; 22: 635-43.
52. Kikuchi H, Furuta A, Nishioka K, Suzuki SO, Nakabeppu Y, Iwaki T. Impairment of mitochondrial DNA repair enzymesagainst accumulation of 8-oxo-guanine in the spinal motor neuronsof amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 2002; 103:408-14.
53. Deng G, Su JH, Ivins KJ, Van Houten B, Cotman CW. Bcl-2facilitates recovery from DNA damage after oxidative stress. Exp Neurol 1999; 159: 309-18.
54. Ozawa T, Hayakawa M, Katsumata K, Yoneda M, Ikebe S, Mizuno Y. Fragile mitochondrial DNA: the missing link in theapoptotic neuronal cell death in Parkinson's disease. Biochem Biophys Res Commun 1997; 235: 158-61.
55. Butterfield DA, Koppal T, Howard B, et al. Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-butyl-alpha-phenylnitrone and vitamin E. Ann N Y Acad Sci 1998; 854: 448-62.
56. Aksenova MV, Aksenov MY, Payne RM. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders. Dement Geriatr Cogn Disord 1999; 10: 158-65.
57. Amos A, McCarthy D, Zimmet P. The rising global burden of diabetesand its complications: estimates and projections to the year 2010. Diabet Med 1997; 14: S1-85.
58. Rosembloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999; 22: 345-54.
59. Kannel WB, McGee DL. Diabetes and cardiovascular diseases. The Framingham Study. JAMA 1979; 241: 2035-8.
60. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
61. Hu FB, Stampfer MJ, Haffner SM. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002; 25: c.
62. Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes. 1995; 44:369-74.
63. Kahan SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003; 46: 3-19.
64. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 263: 2893-8.
65. Heilbronn LK, Ravussin E. Calorie restriction and aging: review of theliterature and implications for studies in humans. Am J Clin Nutr 2003; 78: 361-9.
66. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stressactivatedsignaling pathways mediators of insulin resistance and Beta celldysfunction? Diabetes 2003; 52: 1-8.
67. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003; 108: 1912-6.
68. Vinik AI. Diabetic neuropathy: pathogenesis and therapy. Am J Med 1999; 107: 17S-26.
69. Russell JW, Golovoy D, Vincent AM, et al. High glucose induced oxidativestress and mitochondrial dysfunction in neurons. FASEB J 2002; 16: 1738-48.
70. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 1999; 6: 347-63.
71. Folmer V, Soares JC, Rocha JB. Oxidative stress in mice isdependent on the free glucose content of the diet. Int J Biochem Cell Biol 2002; 34: 1279-85.
72. Tsai EC, Hirsch IB, Brunzell JD, Chait A. Reduced plasmaperoxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994; 43: 1010-4.
73. Altomare E, Vendemiale G, Chicco D, Procacci V, Cirelli F. Increased lipid peroxidation in type 2 poorly controlled diabeticpatients. Diabete Metab 1992; 18: 264-71.
74. Sundaram RK, Bhaskar A, Vijayalingam S, et al. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 1996; 90: 255-60.
75. Elhadd TA, Kennedy G, Hill A, et al. Abnormal markers of endothelial cell activationand oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease. Diabetes Metab Res Rev 1999; 15: 405-11.
76. Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processesin that illness. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011; 35: 676-92.
77. Lissi EA, Salim-Hanna M, Sir T, Videla LA. Is spontaneousurinary visible chemiluminescence a reflection of in vivo oxidativestress? Free Radic Biol Med 1992; 12: 317-22.
78. Lissi EA, Salim-Hanna M, Videla LA. Spontaneous urinaryvisible luminescence: characteristics and modification by oxidativestress-related clinical conditions. Braz J Med Biol Res 1994; 27: 1491-500.
79. Oldreive C, Bradley N, Bruckdorfer R, Rice-Evans C. Lack ofinfluence of dietary nitrate/nitrite on plasma nitrotyrosine levelsmeasured using a competitive inhibition of binding ELISA assay.Free Radic Res 2001; 35: 377-86.
80. Devaraj S, Hirany SV, Burk RF, Jialal I. Divergence betweenLDL oxidative susceptibility and urinary F(2)-isoprostanesas measures of oxidative stress in type 2 diabetes. Clin Chem 2001; 47: 1974-79.
81. Leinonen J, Lehtimaki T, Toyokuni S, et al. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 1997; 417:150-2.
82. Gopaul NK, Anggard EE, Mallet AI, et al. Plasma 8-epi-PGF2_ levels are elevated inindividuals with non-insulin dependent diabetes mellitus. FEBS Lett 1995; 368: 225-9.
83. Poulsen HE, Loft S, Prieme H, Oxidative DNA damage in vivo: relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion. Free Radic Res 1998; 29: 565-71.
84. Dandona P, Thusu K, Cook S, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996; 347: 444-5.
85. Moskovitz J, Yim MB, Chock PB. Free radicals and disease.Arch Biochem Biophys 2002; 397: 354-9.
86. Telci A, Cakatay U, Kayali R, et al. Oxidative protein damage in plasma of type 2 diabetic patients. Horm Metab Res 2000; 32: 40-3.
87. Telci A, Cakatay U, Salman S, Satman I, Sivas A. Oxidativeprotein damage in early stage type 1 diabetic patients. Diabetes Res Clin Pract 2000; 50: 213-23.
88. Maddux BA, See W, Lawrence JC Jr, et al. Protection against oxidative stress-induced insulin resistance in rat L6muscle cells by micromolar concentrations of - lipoic acid. Diabetes 2001; 50: 404-10.
89. Maechler P, Jornot L, Wolheim CB. Hydrogen peroxide alters mitochondrialactivation and insulin secretion in pancreatic beta cells. J BiolChem 1999; 274:27905-13.
90. Qujeq D, Davary S, Moazzi Z, Mahjoub S. Effect of Urtica dioica leaf extract on activities of nucleoside diphosphate kinase and acetyl coenzyme A carboxylase, in normal and hyperglycemic rats. Afr J Pharm Pharmacol 2011; 5: 792-6.
91. Rudich A, Tirosh A, Potashnik R, et al. Prolongedoxidative stress impairs insulin-induced GLUT4 translocation in3T3-L1 adipocytes. Diabetes 1998; 47: 1562-9.
92. Talior I, Yarkoni M, Bashan N, Eldar-Fielman H. Increased glucoseuptake promotes oxidative stress and PKC delta activation in adipocytesof obese, insulin-resistant mice. Am J Physiol 2003; 285: E295-E302.
93. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000; 49: 27-9.
94. Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidantenzyme gene expression and antioxidative defense status of insulin producingcells. Diabetes 1997; 46: 1733-42.
95. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. Glucose toxicity in Beta - cells: type 2 diabetes, good radicals gone bad, and theglutathione connection. Diabetes. 2003; 52: 581-7.
96. El-Assad W, Buteau J, Peyot ML, et al.Saturated fatty acids synerize with elevated glucose to cause pancreaticbeta-cell death. Endocrinology 2003; 144: 4154-63.
97. Piro S, Anello M, Di Pietro C, et al. Chronic exposure to free fatty acids orhigh glucose induces apoptosis in rat pancreatic islets: possible role ofoxidative stress. Metabolism 2002; 51: 1340-47.
98. Ross R. The pathogenesis of atherosclerosis: a perspective for 1990s Nature 1993; 326: 801-9.
99. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-78.
100. Mahjoub S, Taghikhani M, Amir Rasouli H, Noohi F. Lipids and lipoproteins status in normal subjects and in acute and stable phases of myocardial infarction. JBUMS 2001; 3: 30-6.
101. Hu FB, Stampfer MJ. Is type 2 diabetes mellitus a vascular condition? Arterioscler Thromb Vasc Biol 2003; 23: 1715-16.
102. Ceriello A., Motz E. Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited. Arterioscler Thromb Vasc Biol. 2004; 24: 816-23.
103. Vincent AM, Russell GW, Low P, Feldman EL. Oxidative Stress in the Pathogenesis of Diabetic Neuropathy. Endocr Rev 2004; 25: 612-28.
104. Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int J Mol Med.1999; 4: 223-30.